Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways. - Wikidata - wikimedia - TriplyDB

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.

http://www.wikidata.org/entity/Q35261803

about

Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway.Role of Forkhead Box Class O proteins in cancer progression and metastasis.KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub.Cancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres.Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement.YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.Leveraging and coping with uncertainty in the response of individual cells to therapy.Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity.

P2860

Q36970403-9B68D6CF-7F36-4DC7-9938-B484317997C7 Q38647185-38CEE9FD-0AF0-49D2-989A-15DA60E99C12 Q41505056-F16BB7D1-9BF2-4728-8FD8-D97FDBEE2117 Q45048442-082B615B-6C74-4A41-967F-F33EACCCD776 Q48240877-2629D920-06FE-4ED2-B7A0-717BAFDD3171 Q48588772-DBF0D998-5AA8-4753-8953-D77A6FBD5C04 Q49390409-2298838D-10AC-4955-B668-E852852DF997 Q52671067-7F0D0CB9-92B7-4C14-AF7C-B520C6F841D3

P2860

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways.

http://www.wikidata.org/entity/Q35261803

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@ast

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@en

type

label

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@ast

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@en

prefLabel

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@ast

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@en

P1433

Q35261803-54116BC8-C7E1-49B6-AD61-DF7B247E908C

P1476

Q35261803-DA911A7E-4A29-4092-8757-42F92D73D989

P2093

Q35261803-09C95595-EAED-4DC8-AC03-463CD7857541

Q35261803-2D0AE690-7145-467B-8CD4-FC808A9817CC

Q35261803-54D605FA-437C-4EEE-8915-829B9ADAEB91

Q35261803-5A2F4949-97D5-4965-B4BE-F2B0B9099113

Q35261803-6EF44F8D-330D-4099-8C43-BC64B452BEF0

Q35261803-7910C04C-1148-44E7-AE23-5D969BA01A50

Q35261803-8968FAE6-EB0D-4E42-A4C7-650484604891

Q35261803-C7B30CFD-78BE-4BA0-8279-2D6F83DDB5EC

Q35261803-E84145F7-4A12-47D0-9604-E4FF425E901D

Q35261803-F5AD688A-CB19-4F90-B22A-15325F96335F

P2860

Q35261803-0778B075-BBCA-4A65-9DC0-AC5BC25F389D

Q35261803-0816407D-7C72-416C-83BC-84CA07D4DF06

Q35261803-0A686DD1-267D-4902-A078-5B3135FEF23C

Q35261803-0CC123D4-D1DA-415F-B820-092209DCC8AD

Q35261803-0D457143-A73B-4E01-8993-C31DE0F1F0EF

Q35261803-0DBA7B55-4030-4B76-9B7C-8EDA7939EB7C

Q35261803-1094D35B-6E78-4FEB-A025-4101A1897428

Q35261803-143F020C-93B2-4CCF-B383-158CB3104C46

Q35261803-17D0F984-619B-49B8-939C-48A0CF77EF38

Q35261803-187FEF0C-508D-4AED-B336-267D348FEEFE

P31

Q35261803-2C0A2FDB-C6DB-435E-9443-60BF98AE2025

P356

Q35261803-E2197D66-502D-40F8-A7AF-5696F7AB66F2

P407

Q35261803-A6F1CF17-C90B-4294-9802-3614933B0F47

P478

Q35261803-2987DBF9-5322-4A62-84F4-D213F23AA973

P577

Q35261803-17116491-911D-4460-A758-1E2268039943

P698

Q35261803-C0EF132E-4B40-423C-93F2-A6053FF23690

P932

Q35261803-19F14283-A2F0-4B87-A9D7-B07952340134

P356

P1433

P1476

Inhibition of mutant EGFR in l ...... 6-dependent survival pathways.

@en

P2093

Alexa B Turke

http://www.w3.org/2001/XMLSchema#string

Anthony C Faber

http://www.w3.org/2001/XMLSchema#string

Daniel A Haber

http://www.w3.org/2001/XMLSchema#string

Elizabeth L Lockerman

http://www.w3.org/2001/XMLSchema#string

Gaylor Boulay

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Engelman

http://www.w3.org/2001/XMLSchema#string

Kyle Concannon

http://www.w3.org/2001/XMLSchema#string

Miguel N Rivera

http://www.w3.org/2001/XMLSchema#string

S Michael Rothenberg

http://www.w3.org/2001/XMLSchema#string

Sarah Cullen

http://www.w3.org/2001/XMLSchema#string

P2860

Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells

Fast and accurate short read alignment with Burrows-Wheeler transform

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

P31

scholarly article

P356

10.7554/ELIFE.06132

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25686219

http://www.w3.org/2001/XMLSchema#string

P932

4384750

http://www.w3.org/2001/XMLSchema#string